MentionFoxImmorta Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-16.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-16 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Immorta Bio, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Immorta Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Immorta Bio, Inc. →Get the full cited report on Immorta Bio, Inc.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Immorta Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Immorta Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $613K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Boris Reznik is named as Executive Officer on the Form D that Immorta Bio, Inc. filed with the SEC on 16 October 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-10-16 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Immorta Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Immorta Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Immorta Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Immorta Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Immorta Bio, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/immorta-bio-inc-form-d-000002